CLL NGS PANEL (FISH+KT+IGHV MUTATION ANALYSIS+NGS TP53 MUTATION ANALYSIS) (SDL10876)

This NGS panel tests FISH, karyotyping, IGHV, and TP53 mutations in CLL. Results guide ibrutinib or venetoclax therapy, predicting aggressive disease and treatment response.